Mar 11,2019

Algorithm uses smartphone camera, flashlight to spot diabetes

According to a release detailing the research, Avram and colleagues collected data from 54,269 adult individuals who had enrolled in UCSF’s Health eHeart Study. These participants had measured their heart rates with the Azumio Instant Heart Rate smartphone app, which uses the phone’s camera and flashlight to measure blood volume variations in the user’s fingertips. The researchers’ model correctly identified 72 percent of the participants with diabetes and increased this rate to 81 percent when incorporating other collected risk factors.

CLINICAL STUDY

#mobile app

View Analyst & Ambassador Comments
Go to original news
Mar 11,2019

23andMe launches predisposition test for Type 2 diabetes

At SXSW in Austin this weekend, consumer genomics company 23andMe unveiled its latest test, a predisposition report on Type 2 diabetes. The test, which has not undergone FDA clearance and does not purport to diagnose a condition, is designed to help people understand when they’re at a higher-than-normal risk for Type 2 diabetes so they can alter their lifestyle.

PRODUCT
View Analyst & Ambassador Comments
Go to original news
Mar 12,2019

Omada adds glucometer, blood pressure cuff to chronic disease management offerings

San Francisco-based digital chronic disease managment company Omada Health announced today that it will add fully integrated, cellular-connected glucometers and blood pressure cuffs to its offerings for Type 2 diabetes and hypertension, respectively.

PRODUCT

#bgm

View Analyst & Ambassador Comments
Go to original news
Mar 12,2019

POPS! one diabetes management system commercially launches

Four months after landing FDA clearance POPS! one, a diabetes management system, is now commercially launching. The system uses an algorithm to give users real-time personalized diabetes coaching. It also includes small glucose meter that attaches to the back of a user’s smartphone. Users can check their glucose levels on the meter and the results will automatically transfer to the app. The platform lets users track their blood glucose levels. Users can decide to share that data with family members or a physician.

PRODUCT

#bgm

#coaching

#mobile app

View Analyst & Ambassador Comments
Go to original news
Mar 14,2019

Virta Health brings in Jiff's old CEO and more digital health hires

Virta Health, the company that controversially claims to reverse Type 2 diabetes using a combination of diet and digitally-powered management efforts, has hired a big name in the digital health space as its new head of commercial: Derek Newell, who served as CEO of Jiff prior to its acquisition by Castlight. Newell stayed on with Castlight as president for a little over a year, according to his LinkedIn, departing the company last August.

View Analyst & Ambassador Comments
Go to original news
Mar 18,2019

Early data shows Livongo lowers blood pressure at six weeks

The study looked at 708 individuals with both diabetes and hypertension. Patients whose blood pressure was higher than 130/80 mm Hg saw their systolic blood pressure drop by an average of 11.2 mm Hg and their diastolic pressure drop by an average of 5.2 mm Hg after six weeks in the program, which included digital coaching and self-monitoring with a smartphone-connected blood pressure cuff.

CLINICAL STUDY

#coaching

#mobile app

View Analyst & Ambassador Comments
Go to original news
Mar 20,2019

Hello Heart taps LifeScan for glucometer integration in diabetes management program

Chronic disease management platform Hello Heart will now integrate with LifeScan OneTouch meters as part of its program for diabetes management.

COLLABORATION PARTNERSHIP

#connected device

#bgm

#mobile app

View Analyst & Ambassador Comments
Go to original news
Mar 25,2019

Senseonics launches program for low-cost Eversense CGM systems

On Friday, Senseonics, maker of the implantable continuous glucose monitoring system Eversense, announced a new program geared towards patients with high-deductible insurance plans or plans that don’t cover the full cost of the CGM.

PRODUCT

#cgm

View Analyst & Ambassador Comments
Go to original news
Mar 27,2019

PatientPoint tackles chronic disease with AMA

Cincinnati, Ohio-based patient and provider engagement company PatientPoint is teaming up with the American Medical Association to help improve the prevention, identification and management of Type 2 diabetes and cardiovascular disease. As part of the collaboration, the tech company will be disseminating AMA-developed chronic disease education and engagement content through its point of care digital platform, which can be found in the waiting rooms and exam rooms of nearly 6,500 practices.

COLLABORATION PARTNERSHIP

#product & service

View Analyst & Ambassador Comments
Go to original news
Mar 28,2019

Digital health company developing minimally invasive CGM Biolinq raises additional $4.75M

This morning Biolinq, a digital health company specializing in minimally invasive continuous glucose monitoring, raised $4.75 million in extended Series A financing. This new capital was led by JDRF T1D Fund, Aphelion Capital and LifeSci Venture Partners.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES